Gut check: could your microbiome affect cancer brain fog?

NCT ID NCT06098404

First seen Jan 10, 2026 · Last updated Jun 19, 2026 · Updated 26 times

Summary

This study looks at how gut bacteria might be linked to memory, thinking, and tiredness in people with cancer. Researchers will collect stool samples and do thinking tests at the start and after 6 months of standard cancer treatment. The goal is to find patterns that could help manage these common side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Texas Medical Branch

    RECRUITING

    Galveston, Texas, 77555, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could point toward ways to manage cognitive decline and fatigue in cancer patients by targeting the gut microbiome.

What could go wrong

This is a small, early pilot study that only observes and measures—it does not test any treatment. Results may not lead to direct benefits.

Conditions

The condition(s) this trial relates to.

cancer Fatigue neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.